L’Oréal Paris has introduced its latest scientific innovation, the Melasyl molecule, now powering its Bright Reveal Serum. Developed over 18 years of research and supported by more than 120 scientific studies, Melasyl is designed to precisely target localised pigmentation—including dark spots and post-acne marks—while enhancing and respecting each individual’s natural skin tone.
A study by L’Oréal Groupe, which surveyed 48,000 people across 34 countries, revealed that nearly half of the global population reports at least one skin pigmentation issue. The new serum, fortified with Melasyl, has already demonstrated impressive results in cosmeto-clinical trials, reportedly reducing 86% of dark spots after eight weeks of use.
Dr Richard Betts, PhD, Scientific Director of L’Oréal Consumer Products Division and Head of Scientific Communications for L’Oréal Paris, explained the molecule’s standout performance. “When we clinically tested Melasyl against 13 other anti-pigmentation actives, we saw clear superiority in preventing pigmentation across different skin tones,” he said. He further emphasised the delicate balance required in pigmentation management: “Melanin is crucial for UV protection, but excess production leads to dark spots. Our mission at L’Oréal Paris is to deliver proven, visible results, and Melasyl is a breakthrough in that pursuit.”
Anne Colonna, Global Head of Advanced Research at L’Oréal Groupe, highlighted the inclusive nature of the innovation. “This molecule is what we call an inclusive tone management molecule. It doesn’t block the natural process of pigmentation; instead, it magnifies your own skin tone. It’s about respecting and celebrating the diversity of skin,” she said.
The development of Melasyl is the culmination of a global research effort that evaluated 100,000 different molecules to identify the most effective solution for reducing excess melanin. By directly targeting the source of hyperpigmentation, the Bright Reveal Serum works to fade dark spots without altering the skin’s inherent colour.
The Australian debut of this technology was marked by an event at the L’Oréal Paris Lab in Sydney. During the event, Dr Betts provided guests with an in-depth look at the science behind Melasyl. The event also showcased the debut of Episkin, L’Oréal’s pioneering reconstructed skin technology—an ethical alternative to animal testing—and featured personalised skin consultations with local dermatologist Dr Lee-Mai Yap.
Read the SUMMER ’25 issue of Retail Beauty below:
- For more news and updates, subscribe to our weekly newsletter
- Follow us on Instagram
- Like us on Facebook
- Connect with us on LinkedIn